Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Ebola diagnostics – faster, safer, and more accurate

“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” - says D…


How to prevent Ebola's perfect storm?

The 2014 Ebola outbreak was devastating. The virus affected 4 West African countries: Guinea, Liberia, Nigeria and Sierra Leone, killing some 10.0…


A perspective of the future - Towards a cure for cancer and much more

‘Within 10 years we will be able to cure cancer’. A bold statement? Paul Stoffels (CSO J&J) doesn’t think so. He is a believer. He is also pers…

POPULAR TAGS

Survivors's plasma to treat ebola patients does not meet expectations

Written by DS on in the category news with the tags , .


Ebola Tx is the largest clinical study ever performed with blood plasma of people that survived Ebola, to treat the disease. The study was performed in Guinea by the Institute of Tropical Medicine (ITM) in Antwerp. The results of the study, which took place in 2015 during the  Ebola epidemic, not only show that this treatment is feasible, but also that it presents no risk. The treatment causes very few side effects. However, the effectiveness needs to be further examined.

Johan van Griensven, the professor that coordinates the study at ITM, turned out to be somewhat disappointed by the fact that the treatment did not significantly improve the survival of patients. "But this doesn’t mean that the study was not useful, “ says Griensven. More research is necessary to explore the benefits of plasma transfusion of ebola survivors, before a final conclusion can be made.

In a letter in the NEJM on November 14, the researchers examined whether the dose of antibodies administered to the patients, could be associated with the effectiveness of the treatment. Patients who received a higher dose of Ebola antibodies in fact showed a lower viral load after the transfusion, but unfortunately, there was no significant correlation with mortality. On October 31, the project was officially closed.

Read more about ebola

Read more about: , .

RELATED ARTICLES
Ebola diagnostics – faster, safer, and more accurate

“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” - says D…


How to prevent Ebola's perfect storm?

The 2014 Ebola outbreak was devastating. The virus affected 4 West African countries: Guinea, Liberia, Nigeria and Sierra Leone, killing some 10.0…


A perspective of the future - Towards a cure for cancer and much more

‘Within 10 years we will be able to cure cancer’. A bold statement? Paul Stoffels (CSO J&J) doesn’t think so. He is a believer. He is also pers…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Itera Life Science XpandInnovation V-Bio Ventures Flanders.bio Turnstone Janssen KU Leuven UGent GSK Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.